NB

Nicholas Benedict

Europe, Basel-Stadt, Switzerland, Basel

Description

Nicholas has over 20 years experience in the pharma industry, starting in finance in F. Hoffmann-La Roche before moving to marketing and sal...

Investor Profile

Nicholas Benedict has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Series B (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nicholas Benedict frequently co-invest with?

Edmond de Rothschild Private Equity
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Delos Capital
North America, New York, United States, New York
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
EMBL Ventures
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 1

What are some of recent deals done by Nicholas Benedict?

Allecra Therapeutics

Weil Am Rhein, Baden-Wurttemberg, Germany

Allecra is a biopharmaceutical company focused on the development of novel treatments to combat multi-drug-resistant bacterial infections.

BiopharmaBiotechnologyPharmaceutical
Series BJun 15, 2016
Amount Raised: $24,780,328